Ad
Wednesday, 2 May 2018
Accounting concerns wipe $6 billion off Samsung BioLogics market value
SEOUL (Reuters) - South Korean biotech drug manufacturer Samsung BioLogics Co Ltd lost almost $6 billion in market value on Wednesday in its biggest intra-day share drop, after the country's financial watchdog said it breached accounting rules.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment